Abstracts tagged "self-management and treatment"

Abstract Number: 1990 • 2017 ACR/ARHP Annual Meeting
Effectiveness and Durability of a Brief Multidisciplinary Treatment Program for Patients with Fibromyalgia
Jessica Gehin¹, Andy Abril², Fernando Rivera³, Benjamin Wang⁴, Ronald Butendieck², Florentina Berianu², Kenneth Calamia², Madeleine Allman¹, Isabel Abril¹ and Barbara Bruce¹, ¹Department of Psychiatry and Psychology, Mayo Clinic Florida, Jacksonville, FL, ²Division of Rheumatology, Mayo Clinic Florida, Jacksonville, FL, ³Division of Consultative and Diagnostic Medicine, Mayo Clinic Florida, Jacksonville, FL, ⁴Rheumatology, Mayo Clinic Florida, Jacksonville, FL
Background/Purpose: Fibromyalgia (FM) effects upwards of 60 million adults in the US alone. The disability and psychological distress often observed in these patients has been…
Abstract Number: 2416 • 2012 ACR/ARHP Annual Meeting
Arthritis-Attributable Interference in Routine Life Activities
Kristina A. Theis¹, Teresa J. Brady², Charles G. Helmick³, Louise Murphy⁴ and Kamil E. Barbour⁵, ¹Athritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ³National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ⁴Division of Population Health, CDC, Atlanta, GA, ⁵Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Arthritis-attributable interference (AAI) in routine life activities are indicators of quality-of-life (QOL) that have not often been studied in a population-based sample of U.S.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].